Lexaria raises $5M via registered direct offering and private placement of warrants

Lexaria Bioscience Corp.

Gross proceeds of $5.0M from sale of 1,633,987 shares at $3.06/share plus 4,551,019 warrants exercisable at $3.06.
Warrants exercisable only after stockholder approval; expire 5 years from approval date.
Included cancellation of 2,917,032 outstanding warrants issued in April 2024.
Net proceeds to be used for working capital and general corporate purposes.
Placement agent H.C. Wainwright receives 7% cash fee and warrants for 57,190 shares at $3.825.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.